News brief October 24, 2023 Lisa Schnirring AstraZeneca today announced that the US Food and Drug Administration (FDA) has agreed to review its application for the option for its FluMist flu vaccine to be self- or caregiver-administered, which if approved will be the first vaccine available for self-administration or by caregivers, offering another option for...
Lucy Hicks August 16, 2023 The US Food and Drug Administration (FDA) has issued a warning letter to AstraZeneca over the pharmaceutical company’s advertising of the efficacy of a treatment for chronic obstructive pulmonary disease (COPD). Promotional materials for the drug Breztri (budesonide/formoterol fumarate/glycopyrrolate inhaled) suggest that the drug has a positive effect on all-cause mortality for COPD patients, but the referenced clinical trial...
This transmission electron microscope image shows SARS-CoV-2 — also known as 2019-nCoV, the virus that causes COVID-19 — isolated from a patient in the US. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Credit:...
Credit: Unsplash/CC0 Public Domain Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms. The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease. A new trial of 5,197 participants who had not been...
Credit: Unsplash/CC0 Public Domain Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms. The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease. A new trial of 5,197 participants who had not been...
Credit: Unsplash/CC0 Public Domain Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms. The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease. A new trial of 5,197 participants who had not been...
Published Aug. 2, 2021 Jonathan Gardner Senior Reporter Christopher Furlong via Getty Images Dive Brief: The Food and Drug Administration has approved AstraZeneca’s drug Saphnelo for the treatment of systemic lupus, the British pharma announced Monday, making the antibody the first new drug cleared for the autoimmune condition since GlaxoSmithKline won approval for Benlysta in 2011....
by Sylvia Hui A view of an empty Regent Street, during what would normally be the Boxing Day sales. Boxing Day spending is expected to fall by more than a quarter compared with a year ago, after extensive new COVID-19 restrictions forced non-essential retailers to close, in London, Saturday, Dec. 26, 2020. (Stefan Rousseau/PA via...
